The Swiss Market Index (SMI) declined 0.41% at the open on Tuesday, weighed down by losses among heavyweights Roche (-1.3%) and Novartis (-0.9%), as negative momentum from U.S. markets extended into Europe.
U.S. equities faced pressure overnight as rising Treasury yields, elevated oil prices, and weak Walmart earnings dampened sentiment. Concerns over the U.S. national debt, now exceeding $40 trillion, added to investor unease. In Switzerland, the economic calendar remained sparse, with only a handful of mid-tier companies scheduled to report earnings.
Analysts cautioned that market conditions were shifting, with potential for increased volatility if oil and bond yields continue to rise. The earnings season, once a key support for markets, is nearing its conclusion; Nvidia is set to deliver its final major report among the "Magnificent Seven" next week.
Elsewhere, Holcim gained 0.4% after announcing its acquisition of Germany-based Fermacell for €840 million. The deal follows the cement producer's recent expansion strategy. Kühne+Nagel rose 0.5% as reduced ship transits through the Panama Canal, due to low water levels, are expected to tighten freight rates.
Among companies reporting half-year results, Siegfried advanced 3.4% after beating expectations and reaffirming its outlook. Georg Fischer climbed 1% following an upgrade to "Buy" by Research Partners, while Komax slipped 0.3% despite UBS raising its price target. Vetropack surged 6.5% on its earnings update.
